• Publications
  • Influence
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
This randomized, controlled trial assessed the efficacy of transarterial Lipiodol (Lipiodol Ultrafluide, Laboratoire Guerbet, Aulnay‐Sous‐Bois, France) chemoembolization in patients with unresectableExpand
  • 2,129
  • 93
  • PDF
Significance of CD90+ cancer stem cells in human liver cancer.
This study characterized cancer stem cells (CSCs) in hepatocellular carcinoma (HCC) cell lines, tumor specimens, and blood samples. The CD90+ cells, but not the CD90(-) cells, from HCC cell linesExpand
  • 1,056
  • 67
  • PDF
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
BACKGROUND & AIMS We aimed to develop a prognostic classification scheme with treatment guidance for Asian patients with hepatocellular carcinoma (HCC). METHODS We collected data from 3856 patientsExpand
  • 389
  • 32
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma
Recent studies have shown that the prognosis of recurrent hepatocellular carcinoma (HCC) after resection was dependent on the time of recurrence. The current study investigated whether early and lateExpand
  • 622
  • 28
A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
Recent evidence suggests that a subpopulation of cancer cells, cancer stem cells (CSCs), is responsible for tumor growth in colorectal cancer. However, the role of CSCs in colorectal cancerExpand
  • 453
  • 28
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
Vascular invasion and high histologic grade predict poor outcome after surgical resection or liver transplantation for hepatocellular carcinoma (HCC). Despite the known association between tumor sizeExpand
  • 448
  • 27
Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function: Implications for a Strategy of Salvage Transplantation
ObjectiveTo evaluate the survival results and pattern of recurrence after resection of potentially transplantable small hepatocellular carcinomas (HCC) in patients with preserved liver function, withExpand
  • 717
  • 24
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Yes‐associated protein (YAP), a downstream target of the Hippo signaling pathway, was recently linked to hepatocarcinogenesis in a mouse hepatocellular carcinoma (HCC) model. The objective of theExpand
  • 416
  • 24
Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition
Purpose: Hepatocellular carcinoma (HCC) is a rapidly growing tumor associated with a high propensity for vascular invasion and metastasis. Epithelial-mesenchymal transition (EMT) is a key event inExpand
  • 369
  • 21
  • PDF
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.
Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in adults and the third most common cause of cancer death worldwide. The incidence of HCC in the United States isExpand
  • 322
  • 17